| Product Name |
Recombinant Human Eukaryotic Interleukin 13 (IL13) Protein |
| Product Overview |
This recombinant human Eukaryotic Interleukin 13 (IL13) protein includes amino acids 25-146aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id |
P35225 |
| Recommended Name |
Interleukin-13 |
| Gene Name |
IL13 |
| Synonyms |
Interleukin-13;IL-13; |
| Species |
Human |
| Predicted Molecular Mass |
68 kDa |
| Expression System |
Mammalian Cell |
| Expression Range |
25-146aa |
| Tag |
C-Fc |
| Purity |
>95% |
| Formulation |
Lyophilized |
| Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Cytokine, Immunology |
| Target Function |
Cytokine. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages. |
| Subcellular Location |
Secreted. |
| Protein Family |
IL-4/IL-13 family |
| Associated Diseases |
Allergic rhinitis (ALRH) |
